baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Kuros Biosciences AG KUROS BIOSCI.../ CH0325814116 /

5/23/2024 5:11:52 PM	Chg. -	Volume	Bid6:00:06 AM	Ask6:00:06 AM	Market Capitalization	Dividend Y.	P/E Ratio
7.970CHF	-	520 Turnover: 4,135.590	-Bid Size: -	-Ask Size: -	912.21 mill.CHF	-	-

Newsfile Corp 9/4 CSE Bulletin: Delist - Isracann Biosciences Inc. (IPOT)

GlobeNewswire 8/31 Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates

GlobeNewswire 8/30 Ventyx Biosciences Announces Departure of Chief Financial Officer

GlobeNewswire 8/29 Annexon Biosciences to Participate in Upcoming September Investor Conferences

GlobeNewswire 8/28 Aura Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire 8/28 Ventyx Biosciences to Participate in Two Upcoming Investor Conferences

GlobeNewswire 8/28 Elevai Labs Inc. Files Combination Patents with Yuva Biosciences for Breakthrough Hair and Scalp Car...

GlobeNewswire 8/26 Caribou Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire 8/21 Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility

GlobeNewswire 8/14 Sagimet Biosciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

GlobeNewswire 8/14 IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire 8/13 Solid Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire 8/13 Artelo Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 8/13 Cellectar Biosciences Reports Financial Results for Q2 2024 and Provides a Corporate Update

GlobeNewswire 8/12 Junshi Biosciences Announces Acceptance of Supplemental New Drug Application for Toripalimab as Firs...

GlobeNewswire 8/12 Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer

GlobeNewswire 8/8 Coherus BioSciences Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 8/8 Assembly Biosciences Reports Second Quarter 2024 Financial Results and Recent Updates

GlobeNewswire 8/8 Cytek Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire 8/8 Ventyx Biosciences Reports Second Quarter 2024 Financial Results and Highlights Recent Corporate Pro...

GlobeNewswire 8/8 Aura Biosciences Reports Second Quarter 2024 Financial Results and Business Highlights

GlobeNewswire 8/6 Cytek Biosciences Reports Second Quarter 2024 Financial Results

GlobeNewswire 8/6 Caribou Biosciences Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 8/6 Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2024 Financial Results

GlobeNewswire 8/5 Akoya Biosciences Reports Second Quarter 2024 Financial Results

Kuros Biosciences AG KUROS BIOSCI.../ CH0325814116 /

If you wish to receive reply to your feedback, please provide your email address.